Basic Information
| LncRNA/CircRNA Name | RAET1K |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | RT-PCR, Western blot |
| Sample | LUAD tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | The lncRNA RAET1K/miR-135a-5p axis might participate in the regulation of LUAD progression by influencing CCNE1 expression and the accumulation of cells arrested at the G1/S phase boundary. |
| Pubmed ID | 32010197 |
| Year | 2020 |
| Title | Long Noncoding RNA RAET1K Enhances CCNE1 Expression and Cell Cycle Arrest of Lung Adenocarcinoma Cell by Sponging miRNA-135a-5p |
External Links
| Links for RAET1K | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |